HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Brecht De Tavernier Selected Research

Aprotinin (Trasylol)

10/2022Modulation of thromboinflammation in hospitalized COVID-19 patients with aprotinin, low molecular weight heparin, and anakinra: The DAWn-Antico study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Brecht De Tavernier Research Topics

Disease

2COVID-19
10/2022 - 02/2022
1Thromboinflammation
10/2022
1Critical Illness (Critically Ill)
05/2018
1Septic Shock (Toxic Shock Syndrome)
05/2018

Drug/Important Bio-Agent (IBA)

1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
10/2022
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
10/2022
1Aprotinin (Trasylol)FDA Link
10/2022
1Anti-Bacterial Agents (Antibiotics)IBA
05/2018

Therapy/Procedure

1Critical Care (Surgical Intensive Care)
02/2022
1Resuscitation
05/2018
1Fluid Therapy (Oral Rehydration Therapy)
05/2018